Findings provide new insight into the link between seizures and tumor progression; can help develop improved diagnostics and treatments for deadly form of brain cancer
"Between 14 and 28 days after resolution of symptoms, we and others have found up to 30 % of individuals are still positive by the nasal swab, and they have antibodies too,” said Dr. Spitalnik.
FPC Briefing with Dr, Eldad A. Hod, MD, associate professor of pathology an cell biology, and Diana Berrent, COVID-19 survivor and founder of Survivor Corps.
Convalescent plasma has been given to a small number of patients in the U.S. hoping it might help them fight off the virus. But the research is at early stages.
Dr. Eldad Hod talks on his efforts to implement serological testing to identify patients who have recovered from COVID-19 and who may qualify as convalescent plasma donors.
